3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Multiple Myeloma
1
Hematologic Diseases
1
Interventions
pembrolizumab
245
Nivolumab
141
Cisplatin
137
Cyclophosphamide
134
Paclitaxel
115
Carboplatin
108
Gemcitabine
98
Radiotherapy
84
Dexamethasone
83
Docetaxel
77
atezolizumab
69
Ipilimumab
67
Fluorouracil
61
Doxorubicin
61
Blood Specimen Collection
59
Bevacizumab
59
Rituximab
55
fludarabine
54
Etoposide
53
Oxaliplatin
52
Lenalidomide
50
Surveys and Questionnaires
49
Prednisone
47
Standard of Care
45
Magnetic Resonance Spectroscopy
45
Radiosurgery
44
Cetuximab
44
lenvatinib
43
Capecitabine
43
durvalumab
42
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Blood Viscosity
×
1 year
×
Clear all
NCT06095752
2025-10-02
Multiple Myeloma Prognostic Indices
Assiut University
Completed
48 enrolled